The use of Fetal Pulse Oximetry in determining fetal wellbeing during labour

The use of Fetal Pulse Oximetry in determining fetal wellbeing during labour: A non-randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202010913594375

Enrollment

100

Registered

2020-10-30

Start date

2021-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Fetal pulse oximetry

Fetal cardiotocography

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older 2. Singleton gestation 3. More than 34 weeks’ gestation 4. Vertex presentation 5. Ruptured membranes

Exclusion criteria

Exclusion criteria: 1. Patients on trial for vaginal delivery after cesarean section 2. Fetus with known congenital anomalies 3. Chorioamnionitis 4. Preeclampsia/Hemolysis Elevated Liver Enzymes Low Platelets (HELLP) syndrome 5. Suspected Small for Gestational Age (SGA)/Intra-uterine Growth Restriction (IUGR) 6. Stillbirth 7. Maternal pulmonary disease with O2 saturation in labor < 95% 8. Any condition that precludes ROM or vaginal delivery (placenta praevia) 9. Malpresentation 10. Human Immunodeficiency Virus (HIV) disease 11. Multifetal gestation 12. Gestational Diabetes Mellitus (GDM)

Design outcomes

Primary

Measure	Time frame
Comparison of an intrauterine fetal pulse oximeter device with other methods of fetal monitoring in determining fetal well-being in labour.	—

Secondary

Measure	Time frame
Fetal oxygen determination in the second stage of labor	—

Countries

Kenya

Contacts

Public ContactMukaindo Mwaniki

Assistant professor

mukaindo.mwaniki@aku.edu+254721379862

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026